Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -59.52M | -61.04M | -59.00M | -50.11M | -49.18M |
| Total Depreciation and Amortization | 7.37M | 8.06M | 9.62M | 9.05M | 8.43M |
| Total Amortization of Deferred Charges | 1.65M | 1.48M | 1.29M | 1.30M | 1.30M |
| Total Other Non-Cash Items | 37.85M | 40.13M | 40.70M | 40.09M | 38.37M |
| Change in Net Operating Assets | -1.93M | -1.56M | -8.58M | -12.49M | -13.82M |
| Cash from Operations | -14.58M | -12.93M | -15.97M | -12.15M | -14.90M |
| Capital Expenditure | -10.47M | -13.04M | -13.52M | -14.19M | -14.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.12M | 20.37M | 26.77M | 21.20M | 18.28M |
| Cash from Investing | 17.65M | 7.33M | 13.25M | 7.01M | 4.03M |
| Total Debt Issued | 60.86M | 60.86M | 60.86M | 1.55M | 983.00K |
| Total Debt Repaid | -57.87M | -57.70M | -57.23M | -507.00K | -98.00K |
| Issuance of Common Stock | 410.00K | 518.00K | 546.00K | 533.00K | 300.00K |
| Repurchase of Common Stock | -720.00K | -708.00K | -902.00K | -858.00K | -446.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.21M | -1.21M | -1.20M | -- | -- |
| Cash from Financing | 1.48M | 1.77M | 2.08M | 721.00K | 739.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.56M | -3.83M | -642.00K | -4.42M | -10.13M |